$2.420
+0.061 (+2.54%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de KLRS por análisis de gráficos similares
Alphio's KLRS stock price prediction model matches the current Kalaris Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.48 (+2.67%). The 1-week path is $2.39 (-1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Kalaris Therapeutics Inc?
Kalaris Therapeutics is currently not a strong buy due to its ongoing financial losses and low RSI of 45.617, indicating a lack of momentum. However, the stock has shown a recent 5-day increase of 11.11%, suggesting potential short-term recovery. The main risk is its negative earnings per share (EPS) of -0.46, which reflects ongoing profitability challenges.
KLRS cerró en $2.42 el Friday, tras subir +2.54%
Kalaris Therapeutics Inc (KLRS) last closed at $2.4200001, gaining +2.54%. These facts feed the 1-day and 1-week KLRS price prediction above.
Factores de la previsión
Los factores de la previsión de Kalaris Therapeutics Inc (KLRS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de KLRS, ordenadas por similitud.
Análisis de estacionalidad de KLRS
Historically the probability of a positive November return for KLRS is 13.64%. February offers the highest probability of a positive month at 58.62%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de KLRS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.85 | $2.13 | $2.37 | -11.86% |
| Dec 2026 | $2.37 | $2.42 | $2.74 | +0.04% |
En 2026, se proyecta que Kalaris Therapeutics Inc (KLRS) oscile entre $1.85 y $2.74.
Previsión mensual de Kalaris Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Kalaris Therapeutics Inc promedie $2.13, con un mínimo de $1.85 y un máximo de $2.37.
En Dec de 2026, se proyecta que Kalaris Therapeutics Inc promedie $2.42, con un mínimo de $2.37 y un máximo de $2.74.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.